316 related articles for article (PubMed ID: 22588704)
1. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
Hoang VT; Zepeda-Moreno A; Ho AD
Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
[TBL] [Abstract][Full Text] [Related]
2. Identification and separation of normal hematopoietic stem cells and leukemia stem cells from patients with acute myeloid leukemia.
Hoang VT; Hoffmann I; Borowski K; Zepeda-Moreno A; Ran D; Buss EC; Wuchter P; Eckstein V; Ho AD
Methods Mol Biol; 2013; 1035():217-30. PubMed ID: 23959995
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
4. Identifying leukemia stem cells--is it feasible and does it matter?
Lutz C; Hoang VT; Buss E; Ho AD
Cancer Lett; 2013 Sep; 338(1):10-4. PubMed ID: 22820159
[TBL] [Abstract][Full Text] [Related]
5. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ
Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948
[TBL] [Abstract][Full Text] [Related]
6. Functional alterations of Lin-CD34+CD38+ cells in chronic myelomonocytic leukemia and on progression to acute leukemia.
Sun Q; So CC; Yip SF; Wan TS; Ma SK; Chan LC
Leuk Res; 2008 Sep; 32(9):1374-81. PubMed ID: 18372040
[TBL] [Abstract][Full Text] [Related]
7. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
8. Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.
She M; Niu X; Chen X; Li J; Zhou M; He Y; Le Y; Guo K
Cancer Lett; 2012 May; 318(2):173-9. PubMed ID: 22198207
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication.
de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L
Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595
[TBL] [Abstract][Full Text] [Related]
10. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
[TBL] [Abstract][Full Text] [Related]
11. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
Jin L; Hope KJ; Zhai Q; Smadja-Joffe F; Dick JE
Nat Med; 2006 Oct; 12(10):1167-74. PubMed ID: 16998484
[TBL] [Abstract][Full Text] [Related]
12. Role of Microenvironment in Resistance to Therapy in AML.
Tabe Y; Konopleva M
Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
[TBL] [Abstract][Full Text] [Related]
13. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo assays to study self-renewal, long-term expansion, and leukemic transformation of genetically modified human hematopoietic and patient-derived leukemic stem cells.
Sontakke P; Carretta M; Capala M; Schepers H; Schuringa JJ
Methods Mol Biol; 2014; 1185():195-210. PubMed ID: 25062630
[TBL] [Abstract][Full Text] [Related]
15. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
Costello RT; Mallet F; Gaugler B; Sainty D; Arnoulet C; Gastaut JA; Olive D
Cancer Res; 2000 Aug; 60(16):4403-11. PubMed ID: 10969785
[TBL] [Abstract][Full Text] [Related]
16. Leukemic Stem Cell (CD34
Mohamed MMI; Aref S; Agdar MA; Mabed M; El-Sokkary AMA
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):508-513. PubMed ID: 33931379
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia stem cells.
Dick JE
Ann N Y Acad Sci; 2005 Jun; 1044():1-5. PubMed ID: 15958691
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cells in hematological disorders: current and possible new therapeutic approaches.
Annaloro C; Onida F; Saporiti G; Lambertenghi Deliliers G
Curr Pharm Biotechnol; 2011 Feb; 12(2):217-25. PubMed ID: 21044004
[TBL] [Abstract][Full Text] [Related]
19. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
20. Identification of murine and human acute myeloid leukemia stem cells.
Deshpande AJ; Ahmed F; Buske C
Methods Mol Biol; 2009; 568():21-35. PubMed ID: 19582419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]